The na-SPMS expanded access program allows patients who do not meet the inclusion criteria for the ongoing Phase 2a clinical trial to receive treatment with Tiziana’s investigational therapy ...

Early-phase clinical trials, including phase 1 and some phase 2a studies, serve as a pivotal step for biotech companies, laying the foundation for a drug candidate’s journey to market.

Originally planned as a two-year study, the trial has been extended by an additional year to collect three-year clinical outcome data The ...

Viking advances VK2735 with a phase 2a study targeting results in H2'25. Phase 3 begins in Q2'25, fueling progress and ...

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Get Free Report) is anticipated to announce its earnings results before the market opens on Thursday, March 6th. Analysts expect the company to announce ...

The Mumbai Metro Rail Corporation (MMRC) announced on February 28 that a trial train arrived at Cuffe Parade, the final ...